Furthermore, the combined detection of these biomarkers has shown great potential for improving the accuracy of prediction and diagnosis.[69] The clinical significance of TIMP-2 and IGFBP-7 in predicting CSA-AKI is substantial. This evidence concerns the gene IGFBP7 and acute kidney injury.